Two new studies show the potential of personalized brain stimulation to treat psychiatric disorders. The approach delivers pulses of electric or magnetic energy to certain areas in the brain.
As states suddenly expand the categories of people eligible for the first scarce shipments of vaccine, who will be watching to make sure those hit hardest by the pandemic aren't left behind?
Parler, the messaging app favored by far-right activists, has a new home. NPR's Steve Inskeep talks to Brian Friedberg of Harvard's Shorenstein Center. He tracks social media and hate groups,
It takes time after vaccination for immunity to the virus to build up, and no vaccine is 100% effective. Plus, scientists don't yet know if the vaccine stops viral spread. Here's what's known so far.
CNN's chief medical correspondent says it's never too late to develop new brain pathways. Even small changes, like switching up the hand you use to hold your fork, can help optimize brain health.
Boston Children's Hospital saw a precipitous drop in cases during the spring shutdown, and the trend continues. Researchers are asking why — and what it would take to keep up the change post-pandemic.
Before scientists were even sure black holes existed, an Indian astrophysicist did the math behind Einstein's predictions of what would happen if two black holes collided.
The emergence of COVID-19 started scientists on a year-long, crash course to learn how this virus might travel through the air and how to stop it. They learned a lot, and quickly.
Researchers discovered that an octopus might punch a fish when both are hunting. Although some of the thrown punches can be explained, others remain a mystery.
As the first COVID-19 vaccines begin to be rolled out across the U.S., community leaders in diverse groups already are working hard to dispel misinformation and reach skeptics with truth.
Science writer Robin Marantz Henig has written about dangerous emerging pathogens for 30 years. But none of what she learned could shed light on her own confusing encounter with this virus.
Atlantic writer Ed Yong says the COVID-19 vaccination program will be the most complicated the U.S. has ever attempted: "It's going to be a slow process, and there are a lot of possible roadblocks."
Scientists are calling for efforts to protect hundreds of wild plants in the United States that are related to native foods such as cranberries and chili peppers.
As the first patient to receive an experimental treatment that relied on the gene-editing technique CRISPR continues to do well 17 months later, more patients seem to be benefiting, too.
Within hours, U.S. states are expected have in hand their first shipments of Pfizer's newly FDA-authorized COVID-19 vaccine. It marks a new phase in the pandemic, but what's that mean for you?
A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.
A new study did experiments on millions of Lyft riders to figure out how much they value time. Researchers found time is worth more money than previously thought.
Researchers found that a class of antibodies in a monkey's blood provides protection from COVID-19. If that hold true for humans, a blood test may predict whether a vaccine candidate is working.
Heat waves, air pollution and extreme weather are making people sick and, increasingly, killing people. A key report by global physicians says fossil fuels are to blame.
Social distancing fell dramatically between spring and fall and the gap between Democrats and Republicans widened. But both ends of the political spectrum agree on some measures to fight COVID-19.
The biotech company has new data reinforcing that its COVID-19 inoculation is safe and effective. Moderna is submitting an application to the FDA requesting emergency use authorization.
